Pedro Barata, MD
Biography
- Director, Clinical Genitourinary Medical Oncology Research Program, UH Seidman Cancer Center
Pedro C. Barata, MD, MSc is a board-certified, fellowship-trained medical oncologist at University Hospitals Seidman Cancer Center and an Associate Professor of Medicine at Case Western Reserve University School of Medicine. His special clinical interests include kidney, prostate and bladder cancers.
Dr. Barata is also a renowned clinical trialist and researcher and serves as Director of the Clinical Genitourinary Medical Oncology Research Program at University Hospitals Seidman Cancer Center. His research interests include experimental therapeutics, the molecular profiling of tumors and genomic-based therapies for genitourinary tumors.
After completing his fellowship in medical oncology, Dr. Barata came to the United States in 2016 where he completed a clinical fellowship in experimental therapeutics in genitourinary tumors at the Cleveland Clinic Taussig Cancer Center in Cleveland, Ohio. During that time, he also rotated at the phase I / Experimental Therapeutics Department at MD Anderson Cancer Center, Houston, Texas.
Dr. Barata is an active member in numerous professional committees and societies, including the American Urological Association, the American Society of Clinical Oncology, the American Association for Cancer Research and the Society for Immunotherapy of Cancer.
The recipient of numerous research and education grants, Dr. Barata is a prolific author and co-author, with dozens of published studies and citations to his credit. Most recently, he was named as the Associate Editor of the ASCO Educational Book, an annual publication that serves to educate all members of the oncology care team on practice-changing oncology research so patients can receive the highest-quality, equitable care. Topics for the peer-reviewed articles are selected by ASCO’s Annual Meeting Education Committee and authored by the Annual Meeting Education Program faculty and international experts in oncology. Dr. Barata also serves as the Prostate Cancer Section Editor for the Oncologist journal and is a member of the editorial team of the Translational Oncology journal.
Expertise
- Clinical Research
- Experimental Therapeutics
- GU Medical Oncology
- Kidney Cancer
- Prostate Cancer
Videos
Watch to find out more about this University Hospitals provider.
Languages Spoken
English, Portuguese, Spanish
Office Locations
UH Minoff Health Center at Chagrin Highlands
3909 Orange Pl
Suite: 1100
Beachwood, OH 44122
216-896-1750
UH Minoff Health Center at Chagrin Highlands
3909 Orange Pl
Suite: 1100
Orange, OH 44122
216-844-3951
Patient Experience Reviews
4.8 out of 5
41 Ratings
Patient Comments (4)
Reviewed On 8/1/2023
Always have had excellent encounters with UH staff, doctors, and nurses.
Reviewed On 8/1/2023
Dr Barata was caring, thoughtful and professional
Reviewed On 5/1/2023
Very Good Doctor
Reviewed On 4/1/2023
Excellent Dr.!
Certifications & Memberships
- Internal Medicine - American Board of Internal Medicine
Education
Fellowship | Experimental Therapeutics
Experimental Therapeutics - Cleveland Clinic - Taussig Cancer Center (2016 - 2018)
Fellowship | Medical Oncology
Medical Oncology - Alameda Santo Antonio Dos Capuchos (2013 - 2016)
Other Education
University Of Lisbon, Faculty Of Medicine (2015)
Medical Education
Nova Medical School (2009)
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Pedro Barata did not disclose any Outside Relationships with Industry.